Bioassay with trypomastigotes:
All the extracts were submitted to in vitro biological assay against trypomastigotes blood forms of T. cruzi. The bioassays were carried out usin blood collected by cardiac puncture of Swiss albino mice in the parasitemy peak (seventh day) after infection with the Y strain of T. cruzi. The blood was diluted with not infected murine blood to give a concentration of ca. 2 x 10 6 trypomastigote forms/ml. Stock solutions of the extracts to be tested were prepared by dissolution in DMSO (dimethyl sulfoxide) to a final concentration of 25 mg/ml. The bioassays were performed in triplicate on microtitre plates (96 wells) which contained 200 ml of mixture/well. To each sample, aliquots of the stock solutions were added to the diluted blood in such quantities as to give final concentrations of 4,0 mg/ml sample per mL of mixture in the wells. The plates were incubated at 4 o C during 24 h and the number of parasites determined according to Brener 10 . Controls were blood of infected mice without any addition, infected blood containing DMSO in equivalent amounts as the samples, and infected blood containing gentian violet (positive control) at a concentrations of 250 mg/ml.
Abstract
Dichloromethane crude extract from xylopodium of Calea uniflora Less (Heliantheae-Asteraceae) showed in vitro trypanocidal activity against trypomastigote forms of Trypanosoma cruzi. The data obtained allow to conclude that the crude extract must be investigate to identify its active compounds.
American trypanosomiasis (Chagas' disease) is a severe disease that occurs in Latin America. It is caused by flagellate protozoan Trypanosoma cruzi, transmitted by triatomine insects and by blood transfusion. To develop strategies for keeping the vector insect population and to prevent infection by blood transfusion are two ways for controlling the disease 1 . Gentian violet is the only chemoprophylatic agent employed for this purpose. Although it may cause undesirable effects in the patients 2 . New chemicals for use in banked blood or drugs for treatment of acute and chronic infections are urgently required 3 . Plant extracts may be potential sources of such compounds. Calea uniflora Less is a plant belonging to the tribe Heliantheae, family Asteraceae. The genus contains about 110 species and are found in Mexico, Central and South America 4 . It is important to note that some species of the genus Calea are used for stomach disease 5, 6, 7, 8 . Cerain et al. 9 observed cytotoxic activity of Calea glomerata extract. In this work we report the results of the evaluation of the in vitro trypanocidal activity of Calea uniflora extracts. The trypanocidal bioassay are shown in Table 1 
The ethanolic extract (EE) of Acosmium subelegans (Mohlenbr) Yakovl (perobinha-do-campo) was tested to behavioral paradigms in mice to investigate its putative central depressant effect. Oral pretreatment with the EE significantly reduced in a dose-dependent way the locomotor activity and increased by 30-55% the barbiturate sleep duration relatively to control values. At the highest dose (1,0 g.kg -1 ) it decreased the extension time/flexion time ratio of the maximal electroshockinduced convulsions, enhanced the latency to the pentylenetetrazol-induced convulsions and diminished by 26% the number of seizures, indicating an anticonvulsant action. No changes were observed in the motor coordination, the core temperature, climbing behavior, catalepsy and the plus-maze performance. The preliminary results indicate that the EE of A. subelegans induce a CNS depressant effect, more specifically an anticonvulsant effect that deserve a thorough investigation.
Acosmium subelegans (Mohlenbr) Yakovl, Leguminaceae, popularly known as "perobinha-do-campo", is used in the Brazilian folk medicine as sedative or "tranquilizer", in epilepsy treatmenr, in hysteria, nervous breakdown and chorea 1 . Previous pharmacological studies described that the benzenic extracts obtained from the related species Acosmium dasycarpum (Vog) Yakovl produced a depressant effect upon the central nervous system (CNS) of rats and mice, revealed by a potentiation of barbiturate-sleep, a reduction of the spontaneous and the amphetamine-induced locomotor activity. No protection against pentylenetetrazol and stricnine-induced convulsions was seen 2 . The extract main active constituent was identified as lupeol, a triterpene compound. Lupeol, also reduced the ambulation of mice and potentiated the barbiturate-hypnosis without affecting the animals motor coordination 3 . Comparatively, the ethanolic extract of A. subelegans presented a similar profile of action, decreasing the locomotion in rats 4 and potentiating the barbiturate-induced sleep in mice 5 . 
